• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS SANTA CLARA MYNX CONTROL; DEVICE, HEMOSTASIS, VASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS SANTA CLARA MYNX CONTROL; DEVICE, HEMOSTASIS, VASCULAR Back to Search Results
Catalog Number MX5060E
Device Problem Premature Activation (1484)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/04/2023
Event Type  malfunction  
Manufacturer Narrative
As reported, when using a 5f mynx control vascular closure device (vcd), the user attempted to deploy the mynx sealant by pressing button 1 but was unable to do so due to a faulty button.The button did not have any visible damage and could not be depressed at all.No patient injuries were reported, and hemostasis was achieved by manual compression for twenty-five (25) minutes, resulting in no extended hospitalization.The device was used during a transfemoral cerebral angiography using a retrograde approach, and the physician was being trained on its use.The suitability of the femoral artery was verified on angiography, including the insertion angle (30-45 degrees) of the vascular sheath introducer, as per the instructions for use (ifu).The vessel type was the femoral arterial, and its diameter was verified to be greater than 5 mm.The mynx vcd was prepared according to the ifu.The device storage temperature did not exceed 25 °c.There were no visible signs of device/package damage prior to use.The puncture site did not have visible calcium/plaque or vessel tortuosity nor a stent near the puncture site.There was no vessel stenosis of greater than fifty percent (50%) at or near the puncture site.The tension indicator was aligned with the markers on the handle halves before attempting to deploy the device.A non-sterile ¿mynx control vcd 5f¿ involved in the reported complaint was returned for investigation.Visual inspection of the received device showed that button 1 and button 2 were not depressed with the stopcock opened, the syringe was received connected to the device, the sealant was found partially exposed from the sealant sleeves assembly, which were observed to have been slightly kinked/bent as received.In addition, the procedural sheath was not received for evaluation and the balloon was observed fully deflated.Per functional analysis, a simulated deployment test was performed on the returned device per the mynx control ifu, step 2: deploy sealant.Button 1 was able to be depressed to deploy the sealant with no resistance felt.No issues were noted with respect to button 1 deployment during the device failure investigation.The returned device performed as intended per the mynx control ifu.Button #2 was able to be fully depressed, and no issues were noted with respect to button 2.Per microscopic analysis, visual inspection at high magnification showed that the sealant was found partially exposed from the sealant sleeves assembly due to the slightly kinked/bent condition observed as received.The reported event of ¿button #1-frozen/locked¿ was not confirmed through analysis of the returned device since it passed functional analysis.Additionally, a condition was noted in the returned device of ¿mynx control system-deployment difficulty-premature¿ as a partial exposure of the sealant was observed due to the slightly kinked/bent condition of the sealant sleeves noted.However, the exact cause of the issue experienced by the customer and the premature exposure of the sealant could not be conclusively determined during analysis.Based on the information available for review and product analysis, it is difficult to determine what factors may have contributed to frozen/locked button 1 experienced since it passed functional analysis.However, handling factors (physician was being trained on its use) are possible.Additionally, procedural/handling factors possibly resulted in the kinked/bent condition of the sealant sleeves (such as excessive force during insertion) and the subsequent premature exposure of the sealant.It should be noted that the mynx control device is manufactured with a slit at the end of the catheter cartridge tubing.The outer sleeve is assembled with 2 side slit overlapping outer sleeves.The sealant is placed right under the outer sleeve assembly and is protected from exposing prematurely.The slits on the outer sleeve assembly are designed to decrease unsheathing force and increase deployment reliability.Refer to the diagram of the mynx control vcd within the ifu displaying the sealant sleeve with slit.If the outer sleeve is damaged/kinked during prepping phase and/or insertion into sheath, it could cause the sealant to be exposed/swollen prematurely.However, as this condition was not reported by the customer, it is unknown if this condition occurred during use in the procedure.Although not intended as a mitigation of risk, the information for safety within the ifu is provided in the product¿s labeling with the intent to make the user aware of the risks.According to the mynx control ifu, ¿grasp the device handle and align the device with the tissue tract.Pull gently to retract the device until the black line in the tension indicator window aligns with the markers on the side, indicating the balloon is abutting the arteriotomy with the correct amount of tension.While maintaining tension press button #1 until it is fully aligned with the handle, and the clock symbol is visible in the tension indicator window.¿ the ifu also warns, ¿do not use if components or packaging appear to be damaged or defective or if any portion of the packaging has been previously opened.¿ neither the product analysis, nor the information available for review suggest that the issues experienced could be related to the design or manufacturing process of the unit.Therefore, no corrective/preventative actions will be taken at this time.
 
Event Description
As reported, when using a 5f mynx control vascular closure device (vcd, the user attempted to deploy the mynx sealant by pressing button1 but was unable to do so due to a faulty button.The button did not have any visible damage and could not be depressed at all.No patient injuries were reported, and hemostasis was achieved by manual compression for twenty-five (25) minutes, resulting in no extended hospitalization.The device was used during a transfemoral cerebral angiography using a retrograde approach, and the physician was being trained on its use.The suitability of the femoral artery was verified on angiography, including the insertion angle (30-45 degrees) of the vascular sheath introducer, as per the instructions for use (ifu).The vessel type was the femoral arterial, and its diameter was verified to be greater than 5 mm.The mynx vcd was prepared according to the ifu.The device storage temperature did not exceed 25 °c.There were no visible signs of device/package damage prior to use.The puncture site did not have visible calcium/plaque or vessel tortuosity nor a stent near the puncture site.There was no vessel stenosis of greater than fifty percent (50%) at or near the puncture site.The tension indicator was aligned with the markers on the handle halves before attempting to deploy the device.The device was received for evaluation.Visual inspection of the device at high magnification found the sealant was partially exposed from the sealant sleeves assembly.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MYNX CONTROL
Type of Device
DEVICE, HEMOSTASIS, VASCULAR
Manufacturer (Section D)
CORDIS SANTA CLARA
5452 betsy ross drive
santa clara, california 95054
Manufacturer (Section G)
CORDIS SANTA CLARA
5452 betsy ross drive
santa clara, california 95054
Manufacturer Contact
karla castro
14201 nw 60th avenue
miami lakes, florida 33014
7863138372
MDR Report Key18483622
MDR Text Key332551987
Report Number3004939290-2024-00015
Device Sequence Number1
Product Code MGB
Combination Product (y/n)N
Reporter Country CodeKS
PMA/PMN Number
P040044
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 01/10/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberMX5060E
Device Lot NumberF2306703
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/29/2023
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 12/29/2023
Initial Date FDA Received01/10/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/08/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
NO INFORMATION.
Patient EthnicityNon Hispanic
Patient RaceAsian
-
-